LPCN 1021
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LPCN 1021, covering 2017-10-23 to 2017-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism [Phase 3]